Relationship between first radioactive iodine administration time and initial response to treatment in patients with papillary thyroid carcinoma
Publish place: Iranian Journal of Nuclear Medicine، Vol: 30، Issue: 2
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 187
This Paper With 8 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IRJNM-30-2_001
تاریخ نمایه سازی: 8 تیر 1401
Abstract:
Introduction: The initial post-surgical radioactive iodine (RAI) therapy for patients with papillary thyroid cancer (PTC) is postponed due to increased demand as well as the limited number of centers to provide RAI therapy. Hence, our aim was to investigate the role of first RAI administration time following thyroidectomy on the number of incomplete response (IR) during the initial follow up, while considering other prognostic factors. Methods: Two hundred and thirty-five PTC patients who were admitted to our department for RAI therapy were included in this study. They were allocated into two groups with <۳ months (early group) and ≥ ۳ months (delayed group) time interval after the first RAI therapy, and the total thyroidectomy. Then, based on the response to RAI therapy, patients were categorized as excellent, biochemical incomplete, structural incomplete, or indeterminate responses (ER, BIR, SIR or IDR, respectively).Results: With respect to age, gender, pathologic variables, RAI dose rate and IR (BIR+SIR) rate, significant differences were found between the two groups. The findings identified that early RAI failed to affect the rate of IR (univariate analysis: HR=۱.۰۹, ۹۵%CI: ۰.۶۹-۱.۷۴, P=۰.۷۱; Cox model: HR=۰.۸۱, ۹۵%CI: ۰.۴۶-۱.۴۴, P=۰.۴۷). However, Cox multivariate analysis found lymph node status and thyroglobulin level (Lymph node status: HR=۲.۸۸, ۹۵%CI: ۱.۰۷-۷.۷۸, P=۰ .۰۴) as independent risk factors for IR during the initial follow up.Conclusion: Therefore, timing of the first post-surgery RAI therapy is not a significant prognosticator of the initial response of patients to therapy.
Authors
Tahereh Ghaedian
Nuclear Medicine and Molecular Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Mohammad Ramezani
Nuclear Medicine and Molecular Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Hamideh Sadra
Nuclear Medicine and Molecular Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Marjan Faghih
Department of Biostatistics, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :